肥胖和 2 型糖尿病带来的挑战需要更多地关注食物环境。
Challenges of obesity and type 2 diabetes require more attention to food environment.
机构信息
The BMJ, London, UK.
Correspondence to: E Veitch
出版信息
BMJ. 2023 Oct 9;383:2269. doi: 10.1136/bmj.p2269.
Abstract
The narrative must shift away from individual choice on to structural factors
摘要
叙事必须从个人选择转向结构性因素。
相似文献
1
Challenges of obesity and type 2 diabetes require more attention to food environment.肥胖和 2 型糖尿病带来的挑战需要更多地关注食物环境。
BMJ. 2023 Oct 9;383:2269. doi: 10.1136/bmj.p2269.
2
Diabetes, obesity and soft drinks.糖尿病、肥胖症与软饮料。
Natl Med J India. 2007 Mar-Apr;20(2):102-3.
3
Clinical aspects of obesity and diabetes mellitus.肥胖症与糖尿病的临床方面
West Indian Med J. 2002;51 Suppl 1:26-9.
4
Epidemiology, obesity, and non-insulin-dependent diabetes mellitus.流行病学、肥胖症与非胰岛素依赖型糖尿病
Epidemiol Rev. 1989;11:172-81. doi: 10.1093/oxfordjournals.epirev.a036035.
5
Interrelationships among alcohol abuse, obesity, and type II diabetes mellitus: focus on Native Americans.酒精滥用、肥胖与II型糖尿病之间的相互关系：以美国原住民为重点。
World Rev Nutr Diet. 1988;56:93-172. doi: 10.1159/000416227.
6
Obesity-linked diabetes in the Arab world: a review.阿拉伯世界与肥胖相关的糖尿病：综述
East Mediterr Health J. 2015 Sep 8;21(6):420-39. doi: 10.26719/2015.21.420.
7
Obesity and T2DM in youth.青少年肥胖与2型糖尿病
Endocr Res. 2008;33(1-2):59-72. doi: 10.1080/07435800802080211.
8
Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk.含糖饮料、肥胖、2型糖尿病与心血管疾病风险
Circulation. 2010 Mar 23;121(11):1356-64. doi: 10.1161/CIRCULATIONAHA.109.876185.
9
Obesity and diabetes - an Arctic challenge.肥胖与糖尿病——北极地区面临的挑战。
Int J Circumpolar Health. 2010 Sep;69(4):320-1. doi: 10.3402/ijch.v69i4.17671.
10
American Diabetes Association annual meeting 1996: the etiology of type II diabetes, obesity, and the treatment of type II diabetes.1996年美国糖尿病协会年会：II型糖尿病的病因、肥胖症及II型糖尿病的治疗
Diabetes Care. 1996 Nov;19(11):1311-5. doi: 10.2337/diacare.19.11.1311.
引用本文的文献
1
The Positive Effect of postbiotics on the Glycolipid Metabolism of Induced by High-Glucose Diet.后生元对高糖饮食诱导的糖脂代谢的积极作用。
Nutrients. 2025 Mar 11;17(6):976. doi: 10.3390/nu17060976.
2
Paeoniflorin: a review of its pharmacology, pharmacokinetics and toxicity in diabetes.芍药苷：糖尿病药理学、药代动力学及毒性研究综述
Front Pharmacol. 2025 Apr 7;16:1551368. doi: 10.3389/fphar.2025.1551368. eCollection 2025.
3
Southeast Asia burden and trend of Gastrointestinal tract cancers from 1990 to 2021 and its prediction to 2050: findings from the Global Burden of Disease Study 2021.1990年至2021年东南亚胃肠道癌症负担与趋势及其至2050年的预测：全球疾病负担研究2021的结果
Int J Colorectal Dis. 2025 Mar 8;40(1):60. doi: 10.1007/s00384-025-04849-2.
4
Transdermal microneedle-assisted ultrasound-enhanced CRISPRa system to enable sono-gene therapy for obesity.经皮微针辅助超声增强CRISPRa系统实现肥胖症的声基因治疗。
Nat Commun. 2025 Feb 10;16(1):1499. doi: 10.1038/s41467-025-56755-4.
5
Overweight, Obesity, Hypertriglyceridemia, and Insulin Resistance Are Positively Associated with High Serum Copper Levels in Mexican Adults.超重、肥胖、高甘油三酯血症和胰岛素抵抗与墨西哥成年人的高血清铜水平呈正相关。
Metabolites. 2024 May 14;14(5):282. doi: 10.3390/metabo14050282.
本文引用的文献
1
Ultra-processed foods and cardiometabolic health: public health policies to reduce consumption cannot wait.超加工食品与心血管代谢健康：减少此类食品消费的公共卫生政策刻不容缓。
BMJ. 2023 Oct 9;383:e075294. doi: 10.1136/bmj-2023-075294.
2
Non-sugar sweeteners: helpful or harmful? The challenge of developing intake recommendations with the available research.非糖甜味剂：有益还是有害？利用现有研究制定摄入量建议的挑战。
BMJ. 2023 Oct 9;383:e075293. doi: 10.1136/bmj-2023-075293.
3
Evidence for clinical interventions targeting the gut microbiome in cardiometabolic disease.针对代谢性心血管疾病的肠道微生物组的临床干预措施的证据。
BMJ. 2023 Oct 9;383:e075180. doi: 10.1136/bmj-2023-075180.
4
Interwoven challenges of covid-19, poor diet, and cardiometabolic health.新冠疫情、不良饮食与心血管代谢健康交织的挑战。
BMJ. 2023 Oct 9;383:e076810. doi: 10.1136/bmj-2023-076810.
5
Social, clinical, and policy implications of ultra-processed food addiction.超加工食品成瘾的社会、临床和政策影响。
BMJ. 2023 Oct 9;383:e075354. doi: 10.1136/bmj-2023-075354.
6
High but decreasing prevalence of overweight in preschool children: encouragement for further action.学龄前儿童超重患病率高但呈下降趋势：鼓励采取进一步行动。
BMJ. 2023 Oct 9;383:e075736. doi: 10.1136/bmj-2023-075736.
7
Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention.营养可预防或促进非酒精性脂肪性肝病：干预的机会。
BMJ. 2023 Oct 9;383:e075179. doi: 10.1136/bmj-2023-075179.
8
High price and demand for semaglutide means lack of access for US patients.司美格鲁肽的高价格和高需求意味着美国患者无法获得该药物。
BMJ. 2023 Aug 30;382:1863. doi: 10.1136/bmj.p1863.
9
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.全球、地区和国家 1990 年至 2021 年糖尿病负担，以及对 2050 年患病率的预测：2021 年全球疾病负担研究的系统分析。
Lancet. 2023 Jul 15;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22.
10
Government's "feeble" food strategy fails to tackle health challenges, say experts.专家称，政府“无力的”食品战略未能应对健康挑战。
BMJ. 2022 Jun 14;377:o1460. doi: 10.1136/bmj.o1460.
Zotero 插件